Tech Company Financing Transactions
Suono Bio Funding Round
On 7/14/2021, Suono Bio secured $8.5 million in Series A funding from Axil Capital, Mizuho Securities Principal Investment and Taiwania Capital.
Transaction Overview
Company Name
Announced On
7/14/2021
Transaction Type
Venture Equity
Amount
$8,500,000
Round
Series A
Investors
Axil Capital (Lead Investor)
Mizuho Securities Principal Investment (Lead Investor)
Proceeds Purpose
The company will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
501 Massachusetts Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Suono Bio is on a mission to revolutionize what therapeutics may be used to treat diseases. Advances in genomics have enabled a step-shift in our understanding of diseases and relevant targets to treat those diseases but delivery technologies lag.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Kellogg
Chief Operating Officer
Albert Farinha
Chief Technical Officer
Carl Schoellhammer
Co-Founder
Robert Langer
Co-Founder
Gio Traverso
Browse more venture capital transactions:
Prev: 7/13/2021: Frontier Talent venture capital transaction
Next: 7/14/2021: Mark43 venture capital transaction
Share this article
About Database of VC Transactions
We report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs